Tamaki Y - Search Results

1

Loss of heterozygosity on chromosome 16p and 18q in anaplastic thyroid carcinoma.

Kadota M, Tamaki Y, Sekimoto M, Fujiwara Y, Aritake N, Hasegawa S, Kobayashi T, Ikeda T, Horii A, Monden M. Kadota M, et al. Among authors: tamaki y. Oncol Rep. 2003 Jan-Feb;10(1):35-8. Oncol Rep. 2003. PMID: 12469141

2

High expression of two genes selected by iAFLP: a new prognostic factor of estrogen receptor-positive breast cancer.

Aritake N, Tamaki Y, Masuda N, Nakano Y, Monden T, Noguchi S, Monden M. Aritake N, et al. Among authors: tamaki y. Oncol Rep. 2004 Aug;12(2):381-7. Oncol Rep. 2004. PMID: 15254706

3

Comparative genomic hybridization defines frequent loss on 16p in human anaplastic thyroid carcinoma.

Komoike Y, Tamaki Y, Sakita I, Tomita N, Ohue M, Sekimoto M, Miyazaki M, Kadota M, Masuda N, Ooka M, Ohnishi T, Nakano Y, Kozaki T, Kobayashi T, Matsuura N, Ikeda T, Horii A, Monden M. Komoike Y, et al. Among authors: tamaki y. Int J Oncol. 1999 Jun;14(6):1157-62. doi: 10.3892/ijo.14.6.1157. Int J Oncol. 1999. PMID: 10339673

4

Identification of a 7-cM region of frequent allelic loss on chromosome band 16p13.3 that is specifically associated with anaplastic thyroid carcinoma.

Kadota M, Tamaki Y, Sakita I, Komoike Y, Miyazaki M, Ooka M, Masuda N, Fujiwara Y, Ohnishi T, Tomita N, Sekimoto M, Ohue M, Ikeda T, Kobayashi T, Horii A, Monden M. Kadota M, et al. Among authors: tamaki y. Oncol Rep. 2000 May-Jun;7(3):529-33. doi: 10.3892/or.7.3.529. Oncol Rep. 2000. PMID: 10767363

5

Selection of mRNA markers for detection of lymph node micrometastases in breast cancer patients.

Ooka M, Sakita I, Fujiwara Y, Tamaki Y, Yamamoto H, Aihara T, Miyazaki M, Kadota M, Masuda N, Sugita Y, Iwao K, Monden M. Ooka M, et al. Among authors: tamaki y. Oncol Rep. 2000 May-Jun;7(3):561-6. doi: 10.3892/or.7.3.561. Oncol Rep. 2000. PMID: 10767368

6

Mutational analysis of the class I beta-tubulin gene in human breast cancer.

Hasegawa S, Miyoshi Y, Egawa C, Ishitobi M, Tamaki Y, Monden M, Noguchi S. Hasegawa S, et al. Among authors: tamaki y. Int J Cancer. 2002 Sep 1;101(1):46-51. doi: 10.1002/ijc.10575. Int J Cancer. 2002. PMID: 12209587

7

Fatal differentiated thyroid cancer.

Kobayashi T, Asakawa H, Tamaki Y, Umeshita K, Monden M. Kobayashi T, et al. Among authors: tamaki y. J Surg Oncol. 1996 Jun;62(2):123-7. doi: 10.1002/(SICI)1096-9098(199606)62:2<123::AID-JSO8>3.0.CO;2-A. J Surg Oncol. 1996. PMID: 8649038

8

Establishment of anaplastic thyroid carcinoma cell lines useful for analysis of chemosensitivity and carcinogenesis.

Asakawa H, Kobayashi T, Komoike Y, Yanagawa T, Takahashi M, Wakasugi E, Maruyama H, Tamaki Y, Matsuzawa Y, Monden M. Asakawa H, et al. Among authors: tamaki y. J Clin Endocrinol Metab. 1996 Oct;81(10):3547-52. doi: 10.1210/jcem.81.10.8855799. J Clin Endocrinol Metab. 1996. PMID: 8855799

9

Prognostic factors in patients with recurrent differentiated thyroid carcinoma.

Asakawa H, Kobayashi T, Komoike Y, Tamaki Y, Matsuzawa Y, Monden M. Asakawa H, et al. Among authors: tamaki y. J Surg Oncol. 1997 Mar;64(3):202-6. doi: 10.1002/(sici)1096-9098(199703)64:3<202::aid-jso5>3.0.co;2-e. J Surg Oncol. 1997. PMID: 9121150

10

Chemosensitivity of anaplastic thyroid carcinoma and poorly differentiated thyroid carcinoma.

Asakawa H, Kobayashi T, Komoike Y, Maruyama H, Nakano Y, Tamaki Y, Matsuzawa Y, Monden M. Asakawa H, et al. Among authors: tamaki y. Anticancer Res. 1997 Jul-Aug;17(4A):2757-62. Anticancer Res. 1997. PMID: 9252711

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

990 results

Search Page

Filters